Seeking Alpha on MSN12h
Lexicon's sotagliflozin fails to win support of FDA AdComm for diabetes (update)
An FDA advisory committee voted Thursday that it didn’t believe the benefits of Lexicon's (LXRX) diabetes drug sotagliflozin ...